APOTHEEK MEES HAMONT
ActiveSummary
APOTHEEK MEES HAMONT has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €593,323 and a net result of €291,253. Equity has been growing by about 34% per year since 2018. Its solvency ranks better than 54% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 08-12-2006 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2021
- Establishment unit
- 2.159.350.949 3930 Hamont-Achel, since 08-12-2006
- Financial year end
- 31 December
- Peppol
- Reachable since 18-09-2025
Board and ownership
- Hulsbosch KristienDirector · since 30-10-2022
- Apotheek Hulsbosch100%· score 9131-03-2026 annual accounts of Apotheek Hulsbosch
- Apotheek Hulsbosch BVconsolidatesannual accounts 2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €822,661
- ▼ 2.0%
- Turnover
- ≈ €3.0m
- estimated
- Profit
- €291,253
- ▲ 14.8%
- Equity
- €593,323
- ▲ 11.5%
- Total assets
- €1.5m
- ▼ 5.8%
- Employees on 31-12-2025
- 6
- ▼ 14.3%
Score breakdownlowers riskFounded in 2006Liquidity: current ratio 1.71, cash €201,708Figures for financial year 2025 (filed on 15-06-2026)Equity €593,323 (40.1% of total assets)Show the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 55% of them on solvency, 57% on liquidity, 88% on profitability and 63% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 17 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Registered office moved within Hamont-AchelResignation: Mees Management Apotheek BV (director) · Permanent representative: Mees Joris · Appointment: Hulsbosch Kristien (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as APOTHEEK MEES HAMONT: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.3m and €1.8m, founded between 2001 and 2009.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK MEES HAMONT Hamont-Achel | €1.5m | €0.8m |
| DE LUCHTHAVEN APOTHEEK Zaventem | €1.5m | €0.8m |
| PHARMACIE HAUFROID Villers-le-Bouillet | €1.6m | €0.7m |
| Apotheek Heungens - Ghyzelings Merelbeke-Melle | €1.5m | €0.6m |
| APOTHEEK DARQUENNES Boom | €1.3m | €0.7m |
| PHARMACIE CHARUE Fleurus | €1.8m | €0.7m |
| PHARMACIES ENGELS Malmedy | €1.7m | €0.7m |
Key facts about APOTHEEK MEES HAMONT
- What is the company number of APOTHEEK MEES HAMONT?
- The company number of APOTHEEK MEES HAMONT is 0885.525.767. The VAT number is the same number with BE in front: BE 0885.525.767.
- Where is APOTHEEK MEES HAMONT based?
- The registered office is at Michielsplein 15, 3930 Hamont-Achel.Company details
- What does APOTHEEK MEES HAMONT do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK MEES HAMONT?
- The legal form of APOTHEEK MEES HAMONT is Private limited company (BV).
- When was APOTHEEK MEES HAMONT founded?
- APOTHEEK MEES HAMONT was founded on 08-12-2006.
- Is APOTHEEK MEES HAMONT still active?
- Yes, APOTHEEK MEES HAMONT is an active enterprise in the KBO register.
- How many employees does APOTHEEK MEES HAMONT have?
- APOTHEEK MEES HAMONT had an average of 5.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK MEES HAMONT fall under?
- In its 2021 annual accounts, APOTHEEK MEES HAMONT states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTHEEK MEES HAMONT?
- The turnover in financial year 2025 is ≈ €3.0m. This figure is estimated from the gross margin of €822,661 and 47 comparable companies (NACE 477). It probably lies between €2.3m and €4.9m.
- Is APOTHEEK MEES HAMONT profitable?
- In financial year 2025, APOTHEEK MEES HAMONT made a profit of €291,253.
- Where can I find the annual accounts of APOTHEEK MEES HAMONT?
- APOTHEEK MEES HAMONT filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK MEES HAMONT due?
- APOTHEEK MEES HAMONT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.